Austria

Austrian Biotech Efferon Secures €2.5M Seed Funding to Expand Sepsis Treatment Manufacturing Across Europe

by

Efferon, a biotech company developing hemoadsorption devices for treating sepsis and septic shock, has secured €2.5 million in seed funding led by private investors from the DACH region. The company will use funds to build a new EU production facility and expand manufacturing capacity. Efferon’s products include Efferon LPS for general use and Efferon NEO for pediatric patients, with the latter recently receiving CE MDR certification. The technology has been used in over 25,000 treatments across 40+ countries.

Austrian Wellness Group Therme Appoints Former EU Commission Official as Vice President for Global Impact

by

Austrian wellness group Therme Group, founded and led by Romanian businessman Robert Hanea, appointed Ramona Chiriac as Vice President for Global Impact. Chiriac, who ended her mandate as head of the European Commission Representation in Romania in March 2026, will focus on strategic partnerships, institutional relations, and thought leadership on the future of wellness and human development. The appointment reflects Therme Group’s ambitions for international expansion and positioning at the intersection of wellbeing, cities, communities, culture, and societal transformation.

Mistral Acquires Austrian AI Startup Emmi AI to Strengthen Industrial Applications Portfolio

by

Paris-based Mistral has acquired Austrian startup Emmi AI, which develops foundational AI models trained with physics laws to simulate complex engineering processes. This is Mistral’s second acquisition in three months, following the February acquisition of French startup Koyeb. Emmi, created a year ago, raised a €15m seed round and has over 30 employees who will join Mistral. The acquisition demonstrates Mistral’s shift toward vertical specialization in industrial AI.